Company MPX Bioceutical Corp

Equities

MPX

CA5534431021

Delayed Canadian Securities Exchange 5-day change 1st Jan Change
- CAD -.--% Intraday chart for MPX Bioceutical Corp +5.36% +34.09%

Business Summary

MPX Bioceutical Corp, formerly Canadian Bioceutical Corp, is Canada-based company which produces nutraceutical products intended for the treatment of chronic medical conditions where existing treatments fail to meet the needs of patients or where consumers prefer herbal and plant-based medicines out of their concern for the side effects associated with modern pharmaceutical medicines. Its products include CinG-X, Relieva and FertaMax. CinG-X combines standardized cinnamon and ginseng extracts. CinG-X is also an additive that enhances the value of any food, beverage or nutritional supplement and can be combined with various other ingredients. The Company's extract, Psorberine, has been incorporated into both topical cream and lotion products sold under the brand name Relieva. The Company intends to acquire companies engaged in the supply of management and logistical services to medical marijuana dispensaries, production and cultivation businesses in the United States.

Company contact information

MPX Bioceutical ULC

22 Adelaide Street West Suite 2740

M5H 4E3, Toronto

+416-840-3725

http://mpxbioceutical.com/
address MPX Bioceutical Corp(MPX)

Sector

This company's sector is not yet available
  1. Stock Market
  2. Equities
  3. MPX Stock
  4. Company MPX Bioceutical Corp